{
    "root": "bf48c5e0-545e-4832-b40d-47169244742b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": {
        "text": "TOPIRAMATE"
    },
    "value": "20250322",
    "ingredients": [
        {
            "name": "TOPIRAMATE",
            "code": "0H73WJJ391"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE CALCIUM",
            "code": "UTY7PDF93L"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 101",
            "code": "7T9FYH5QMK"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        }
    ],
    "indications": "topiramate indicated : epilepsy : initial monotherapy treatment partial-onset primary generalized tonic-clonic seizures patients 2 years age older ( 1.1 ) ; adjunctive therapy treatment partial-onset seizures , primary generalized tonic-clonic seizures , seizures associated lennox-gastaut syndrome patients 2 years age older ( 1.2 ) preventive treatment migraine patients 12 years age older ( 1.3 )",
    "contraindications": "topiramate initial dose , titration , recommended maintenance dose varies indication age group . full prescribing information recommended , dosing considerations patients renal impairment , geriatric patients , patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions": "topiramate capsules ( sprinkle ) topiramate capsules ( sprinkle ) available containing 15 mg 25 mg topiramate , usp . hard gelatin capsule size `` 2 `` , clear transparent cap imprinted `` tpc `` flesh opaque body imprinted `` 15 `` axially black ink filled white white beads . available follows : ndc 23155-894-06 bottles 60 capsules hard gelatin capsule size `` 1 `` , clear transparent cap imprinted `` tpc `` flesh opaque body imprinted `` 25 `` axially black ink filled white white beads . available follows : ndc 23155-895-06 bottles 60 capsules",
    "adverseReactions": "none .",
    "indications_original": "Topiramate is indicated for: Epilepsy:      initial monotherapy for the treatment of partial-onset or primary      generalized tonic-clonic seizures in patients 2 years of age and older ( 1.1 );      adjunctive therapy for the treatment of partial-onset seizures, primary      generalized tonic-clonic seizures, or seizures associated with      Lennox-Gastaut syndrome in patients 2 years of age and older ( 1.2 ) Preventive treatment of      migraine in patients 12 years of age and older ( 1.3 )",
    "contraindications_original": "Topiramate initial dose, titration, and recommended maintenance dose varies by indication and age group. See Full Prescribing Information for recommended dosage, and dosing considerations in patients with renal impairment, geriatric patients, and patients undergoing hemodialysis ( 2.1 , 2.2 , 2.3 , 2.4 , 2.5 , 2.6 )",
    "warningsAndPrecautions_original": "Topiramate Capsules (Sprinkle)\n                        \n                        Topiramate Capsules (Sprinkle) are available containing 15 mg or 25 mg of topiramate, USP.\n                        Hard gelatin capsule size \"2\", clear transparent cap imprinted with \"TPC\" and flesh opaque body imprinted with \"15\" axially in black ink filled with white to off white beads. They are available as follows:\n                        NDC 23155-894-06\n                        Bottles of 60 capsules\n                        Hard gelatin capsule size \"1\", clear transparent cap imprinted with \"TPC\" and flesh opaque body imprinted with \"25\" axially in black ink filled with white to off white beads. They are available as follows:\n                        NDC 23155-895-06\n                        Bottles of 60 capsules",
    "adverseReactions_original": "None."
}